AstraZeneca PLC vs Pfizer, Inc. — Stock Comparison
AstraZeneca PLC (AZN) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
AstraZeneca PLC scores ahead of Pfizer, Inc. on Q·Score (7.4 vs 6.1 out of 10), led by Quality (8.5 vs 5.7) and Sentiment (7.7 vs 5.2). Pfizer, Inc. scores higher on Health, reflecting stronger balance sheet strength. Analyst consensus targets imply greater upside for AZN (+26.0%) than for PFE (+14.9%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 22% return on equity and 17% profit margins.
Forward P/E of 8.8× is low relative to sector peers.
⚠ earnings contracting 10% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
AZN vs PFE: which stock scores better overall?
Based on Q·Score, AstraZeneca PLC (AZN) scores 7.4/10 versus Pfizer, Inc. (PFE) at 6.1/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: AZN or PFE?
AstraZeneca PLC (AZN) scores higher on Growth (6.1/10 vs 5.1/10). AstraZeneca PLC reports revenue growth (6.4% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is AZN or PFE more attractively valued?
AstraZeneca PLC (AZN) scores higher on Valuation (8.2/10 vs 7.2/10). AZN trades at 14.6× P/E versus PFE at 8.8×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about AZN vs PFE?
There are 10 analysts covering AZN with a consensus price target of $213.69, and 26 analysts covering PFE with a consensus target of $28.75. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: AZN or PFE?
AstraZeneca PLC (AZN) scores higher on Quality (8.5/10 vs 5.7/10). Net profit margin: AZN at 17.0%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: AZN or PFE?
Pfizer, Inc. (PFE) scores higher on Financial Health (7/10 vs 6.4/10). Market beta: AZN at 0.23, PFE at 0.31. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of AZN and PFE?
AstraZeneca PLC (AZN) has a market capitalisation of —, while Pfizer, Inc. (PFE) has a market cap of —. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do AZN or PFE pay dividends?
AZN pays a dividend yield of 1.88%, while PFE pays a dividend yield of 6.88%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →